Research Study2025
Expanding access to gender-affirming hormone therapy via a mobile health clinic: a pilot study.
Streltzov, Nick A.; Sileo, Andrew M.; Kuo, Andrew C.; Sewell, Abigail; Sasson, Abigail; Ewing, Ariel P.; LaRochelle, Jeffrey; Nah, Grace; Hojilla, J. Carlo; Sevelius, Jae M.; Lozier, Alexandra; Garofalo, Robert; Wilson, Erin C.; Trujillo, Daniel; Streed, Carl G. Jr.
Abstract
This pilot study assessed feasibility, acceptability, and preliminary outcomes of initiating gender-affirming hormone therapy (GAHT) on a mobile health clinic (Transhealth Northampton in Massachusetts). Over 9 months, 59 unique patients received GAHT. The intervention demonstrated feasibility, high levels of acceptability and satisfaction (85% of participants rated care as 9-10 out of 10), and was associated with decreases in depression (PHQ-9) and anxiety (GAD-7) measures.
Cite this study:Streltzov, Nick A.; Sileo, Andrew M.; Kuo, Andrew C.; Sewell, Abigail; Sasson, Abigail; Ewing, Ariel P.; LaRochelle, Jeffrey; Nah, Grace; Hojilla, J. Carlo; Sevelius, Jae M.; Lozier, Alexandra; Garofalo, Robert; Wilson, Erin C.; Trujillo, Daniel; Streed, Carl G. Jr. (2025). Expanding access to gender-affirming hormone therapy via a mobile health clinic: a pilot study. BMC Medicine. https://doi.org/https://pubmed.ncbi.nlm.nih.gov/40408525/
Metadata curated by Mission Mobile Medical. Full text is available from the publisher via the DOI link above.